Temporal expression profile of CXC chemokines in serum of patients with spinal cord injury

Neurochemistry International

Volumn 63, Issue 5, 2013, Pages 363-367

  Hassanshahi, Gholamhossein ^a   Amin, Masoud ^a   Shunmugavel, Anandakumar ^b   Vazirinejad, Reza ^a   Vakilian, Alireza ^a   Sanji, Mojtaba ^a   Shamsizadeh, Ali ^a   Rafatpanah, Houshang ^c   Poor, Nahide Masood ^a   Moosavi, Seyyed Reza ^a   Taheri, Saeid ^a,b  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chemokines; Neuroinflammation; Secondary injury; Spinal cord injury

Indexed keywords

CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; STROMAL CELL DERIVED FACTOR 1;

ADULT; ARM INJURY; ARTICLE; CONTROLLED STUDY; FALLING; FEMALE; HUMAN; LEG INJURY; MAJOR CLINICAL STUDY; MALE; NECK INJURY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SPINAL CORD INJURY; TRAFFIC ACCIDENT;

CHEMOKINES; NEUROINFLAMMATION; SECONDARY INJURY; SPINAL CORD INJURY;

ADULT; CHEMOKINES, CXC; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; SPINAL CORD INJURIES;

EID: 84885005683     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.07.012     Document Type: Article

References (22)

1. T. Ara, M. Itoi, K. Kawabata, T. Egawa, K. Tokoyoda, T. Sugiyama, N. Fujii, T. Amagai, and T. Nagasawa A role of CXC chemokine ligand 12/stromal cell-derived factor-1/pre-B cell growth stimulating factor and its receptor CXCR4 in fetal and adult T cell development in vivo J. Immunol. 170 2003 4649 4655 (Pubitemid 36519971)
2. H. Azin, R. Vazirinejad, B.N. Ahmadabadi, H. Khorramdelazad, E.R. Zarandi, M.K. Arababadi, M.N. Karimabad, A. Shamsizadeh, H. Rafatpanah, and G. Hassanshahi The SDF-1 3′a genetic variation of the chemokine SDF-1alpha (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: a study on iranian multiple sclerosis patients J. Mol. Neurosci. 47 2012 431 436
3. G.V. Chaitanya, M. Kolli, and P.P. Babu Granzyme-b mediated cell death in the spinal cord-injured rat model Neuropathology 29 2009 270 279
4. A.H. de Haas, H.R. van Weering, E.K. de Jong, H.W. Boddeke, and K.P. Biber Neuronal chemokines: versatile messengers in central nervous system cell interaction Mol. Neurobiol. 36 2007 137 151 (Pubitemid 351360343)
5. M.J. DeVivo, and Y. Chen Trends in new injuries, prevalent cases, and aging with spinal cord injury Arch. Phys. Med. Rehabil. 92 2011 332 338
6. J.K. Emejulu, and O.C. Ekweogwu Outcome of spinal cord injuries managed in a centre without modern imaging facilities West Afr. J. Med. 28 2009 376 379
7. D. Giulian, M. Corpuz, S. Chapman, M. Mansouri, and C. Robertson Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system J. Neurosci. Res. 36 1993 681 693 (Pubitemid 24002993)
8. R. Gonzalez, M.J. Hickey, J.M. Espinosa, G. Nistor, T.E. Lane, and H.S. Keirstead Therapeutic neutralization of CXCL10 decreases secondary degeneration and functional deficit after spinal cord injury in mice Regen. Med. 2 2007 771 783 (Pubitemid 47554831)
9. J.M. Hall, and K.S. Korach Endocrine disrupting chemicals promote the growth of ovarian cancer cells via the ER-CXCL12-CXCR4 signaling axis Mol. Carcinog 2012
10. I.B. Hansen, T. Ellingsen, N. Hornung, J.H. Poulsen, T. Lottenburger, and K. Stengaard-Pedersen Plasma level of CXC-chemokine CXCL12 is increased in rheumatoid arthritis and is independent of disease activity and methotrexate treatment J. Rheumatol. 33 2006 1754 1759 (Pubitemid 44373206)
11. A. Jaerve, and H.W. Muller Chemokines in CNS injury and repair Cell Tissue Res. 349 2012 229 248
12. C.C. John, A. Panoskaltsis-Mortari, R.O. Opoka, G.S. Park, P.J. Orchard, A.M. Jurek, R. Idro, J. Byarugaba, and M.J. Boivin Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria Am. J. Trop. Med. Hyg. 78 2008 198 205 (Pubitemid 351844547)
13. A.A. Kawu, F.M. Alimi, A.A. Gbadegesin, A.O. Salami, A. Olawepo, T.G. Adebule, and H. Shamsi Complications and causes of death in spinal cord injury patients in Nigeria West Afr. J. Med. 30 2011 301 304
14. F. Knerlich-Lukoschus, B. von der Ropp-Brenner, R. Lucius, H.M. Mehdorn, and J. Held-Feindt Spatiotemporal CCR1, CCL3(MIP-1alpha), CXCR4, CXCL12(SDF-1alpha) expression patterns in a rat spinal cord injury model of posttraumatic neuropathic pain J. Neurosurg. Spine 14 2011 583 597
15. M.C. Kowarik, S. Cepok, J. Sellner, V. Grummel, M.S. Weber, T. Korn, A. Berthele, and B. Hemmer CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation J. Neuroinflammat. 9 2012 93
16. D.J. Mahad, S.J. Howell, and M.N. Woodroofe Expression of chemokines in cerebrospinal fluid and serum of patients with chronic inflammatory demyelinating polyneuropathy J. Neurol. Neurosurg. Psychiatry 73 2002 320 323
17. D. Miljkovic, Z. Stanojevic, M. Momcilovic, F. Odoardi, A. Flugel, and M. Mostarica-Stojkovic CXCL12 expression within the CNS contributes to the resistance against experimental autoimmune encephalomyelitis in Albino Oxford rats Immunobiology 216 2011 979 987
18. M. Rentzos, C. Nikolaou, A. Rombos, F. Boufidou, M. Zoga, A. Dimitrakopoulos, A. Tsoutsou, and D. Vassilopoulos RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis Amyotroph. Later. Scleros. 8 2007 283 287 (Pubitemid 47543094)
19. W. Rong, J. Wang, X. Liu, L. Jiang, F. Wei, X. Hu, X. Han, and Z. Liu Naringin treatment improves functional recovery by increasing BDNF and VEGF expression, inhibiting neuronal apoptosis after spinal cord injury Neurochem. Res. 37 2012 1615 1623
20. A. Rosler, M. Pohl, H.J. Braune, W.H. Oertel, D. Gemsa, and H. Sprenger Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis J. Neurol. Sci. 157 1998 82 89 (Pubitemid 28179540)
21. A. Shunmugavel, M. Khan, P.C. Chou, and I. Singh Spinal cord injury induced arrest in estrous cycle of rats is ameliorated by S-nitrosoglutathione: novel therapeutic agent to treat amenorrhea J. Sex. Med. 9 2012 148 158
22. J. Zajkowska, A. Moniuszko-Malinowska, S.A. Pancewicz, A. Muszynska-Mazur, M. Kondrusik, S. Grygorczuk, R. Swierzbinska-Pijanowska, J. Dunaj, and P. Czupryna Evaluation of CXCL10, CXCL11, CXCL12 and CXCL13 chemokines in serum and cerebrospinal fluid in patients with tick borne encephalitis (TBE) Adv. Med. Sci. 56 2011 311 317